Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2016, Article ID 8057650, 9 pages
http://dx.doi.org/10.1155/2016/8057650
Research Article

Antianemic Treatment of Cancer Patients in German Routine Practice: Data from a Prospective Cohort Study—The Tumor Anemia Registry

1Outpatient Clinic for Hematology and Oncology, Sachsenring 69, 50677 Cologne, Germany
2Outpatient Clinic for Oncology, Kettwiger Strasse 62, 45468 Mülheim an der Ruhr, Germany
3Outpatient Clinic for Oncology, Prinzregentenstrasse 1, 86150 Augsburg, Germany
4Department for Internal Medicine I, Westpfalz-Klinikum, Hellmut-Hartert-Strasse 1, 67655 Kaiserslautern, Germany
5iOMEDICO, Hanferstrasse 28, 79108 Freiburg, Germany
6Outpatient Clinic for Interdisciplinary Oncology and Hematology, Wirthstrasse 11c, 79110 Freiburg, Germany

Received 1 October 2015; Revised 3 December 2015; Accepted 14 December 2015

Academic Editor: Bruno Annibale

Copyright © 2016 Tilman Steinmetz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity,” Vitamin and Mineral Nutrition Information System, Geneva, Switzerland, World Health Organization (WHO/NMH/NHD/MNM/11.1), 2011, http://www.who.int/vmnis/indicators/haemoglobin.pdf.
  2. H. Ludwig, S. Van Belle, P. Barrett-Lee et al., “The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients,” European Journal of Cancer, vol. 40, no. 15, pp. 2293–2306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Steinmetz, U. Totzke, M. Schweigert et al., “A prospective observational study of anaemia management in cancer patients—results from the German Cancer Anaemia Registry,” European Journal of Cancer Care, vol. 20, no. 4, pp. 493–502, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Birgegård, P. Gascón, and H. Ludwig, “Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY,” European Journal of Haematology, vol. 77, no. 5, pp. 378–386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. P. J. Barrett-Lee, H. Ludwig, G. Birgegård et al., “Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey,” Oncology, vol. 70, no. 1, pp. 34–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Bohlius, T. Tonia, E. Nüesch et al., “Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data,” British Journal of Cancer, vol. 111, no. 1, pp. 33–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Steinmetz, M. Kindler, O. Lange, U. Vehling-Kaiser, A. Kuhn, and E. Hellebrand, “A prospective cohort study on the impact of darbepoetin alfa on quality of life in daily practice following anemia treatment guideline revisions,” Current Medical Research and Opinion, vol. 30, no. 9, pp. 1813–1820, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Spivak, P. Gascón, and H. Ludwig, “Anemia management in oncology and hematology,” Oncologist, vol. 14, supplement 1, pp. 43–56, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Cella, M. J. Zagari, C. Vandoros, D. D. Gagnon, H.-J. Hurtz, and J. W. R. Nortier, “Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population,” Journal of Clinical Oncology, vol. 21, no. 2, pp. 366–373, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. S. Aapro and H. Link, “September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agents,” Oncologist, vol. 13, supplement 3, pp. 33–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. D. Rizzo, M. Brouwers, P. Hurley et al., “American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer,” Journal of Clinical Oncology, vol. 28, no. 33, pp. 4996–5010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. NCCN, NCCN Clinical Practice Guidelines in Oncology: Cancer- and Chemotherapy-Induced Anemia, Version 2.2015, National Comprehensive Cancer Network, 2015, http://www.nccn.org/professionals/physician_gls/pdf/anemia.pdf.
  13. Bundesärztekammer BÄK (German Medical Association), “Cross-sectional guidelines for therapy with blood components and plasma derivatives—4th revised edition,” Transfusion Medicine and Hemotherapy, vol. 36, pp. 345–492, 2009. View at Google Scholar
  14. K. Webster, D. Cella, and K. Yost, “The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation,” Health and Quality of Life Outcomes, vol. 1, article 79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Ringash, B. O'Sullivan, A. Bezjak, and D. A. Redelmeier, “Interpreting clinically significant changes in patient-reported outcomes,” Cancer, vol. 110, no. 1, pp. 196–202, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. E. Charlson, P. Pompei, K. L. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar · View at Scopus
  17. FACIT.org, “FACT-An Scoring Guidelines,” Version 4, May 2003.
  18. A. Calabrich and A. Katz, “Management of anemia in cancer patients,” Future Oncology, vol. 7, no. 4, pp. 507–517, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Thomas, “Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin,” Medical Oncology, vol. 15, supplement 1, pp. S13–S18, 1998. View at Google Scholar
  20. P. J. Barrett-Lee, N. P. Bailey, M. E. R. O'Brien, and E. Wager, “Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy,” British Journal of Cancer, vol. 82, no. 1, pp. 93–97, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Bokemeyer, M. S. Aapro, A. Courdi et al., “EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update,” European Journal of Cancer, vol. 43, no. 2, pp. 258–270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Tonia and J. Bohlius, “Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients,” in Hematopoietic Growth Factors in Oncology, vol. 157 of Cancer Treatment and Research, pp. 217–238, Springer, Berlin, Germany, 2011. View at Publisher · View at Google Scholar
  23. T. Tonia, A. Mettler, N. Robert et al., “Erythropoietin or darbepoetin for patients with cancer,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD003407, 2012. View at Google Scholar
  24. H. T. Steinmetz, A. Tsamaloukas, S. Schmitz et al., “A new concept for the differential diagnosis and therapy of anaemia in cancer patients,” Supportive Care in Cancer, vol. 19, no. 2, pp. 261–269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Thomas and L. Thomas, “Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency,” Clinical Chemistry, vol. 48, no. 7, pp. 1066–1076, 2002. View at Google Scholar · View at Scopus
  26. S. B. Yellen, D. F. Cella, K. Webster, C. Blendowski, and E. Kaplan, “Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system,” Journal of Pain and Symptom Management, vol. 13, no. 2, pp. 63–74, 1997. View at Publisher · View at Google Scholar · View at Scopus